Fig. 6From: Effects of neoadjuvant chemotherapy on the contralateral non-tumor-bearing breast assessed by diffuse optical tomographyCorresponding hemoglobin levels map for the contralateral unaffected breast of 46-year-old women classified as RCB III (non-pCR) after Tx12/ACx4 therapy for HER2- breast cancer. MIP images (axial orientation) were acquired at baseline, after 2–3 weeks of NAC (TP1), and at the pre-surgical time point (TP5)Back to article page